'And we have put in place the infrastructure to make that vaccine for the whole of the UK.
Russian Federation had allowed clinical trials of two forms of a potential Covid-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology on June 18. If we go into making a vaccine by using conventional methods and bring a vaccine after two years, then it will be of no use.
'So, assuming that the funding is there to purchase that vaccine, we could have that vaccine rolled out across the United Kingdom in the first half of next year'.
So far, 15 volunteers have been vaccinated, but Professor Shattock says this will be ramped up in the "coming weeks", to include another 200-300 patients.
However, in June the global health monitoring body, World Health Organization (WHO) had announced that Britain's Coronavirus vaccine, developed by Oxford researchers was most advanced and as per many experts, it is the most promising candidate among others. A report published in KOMO News now reveals that Haller, who works as an operations manager in a tech company is not feeling any ill effects after receiving the vaccine shot.
Professor Robin Shattock, who leads a team working to produce a vaccine at Imperial College London, said that enough of the vaccine would be available for every person in the United Kingdom if trials go "really well". We have indigenous candidates and we must not miss the bus.
He said that the although there is no certainty that either the vaccine at Imperial or Oxford could not work, the likelihood of both failing he says is "very low".
As national requirements to assess the environmental risks of clinical trials on medicinal products that contain or consist of GMOs vary considerably across member states, a derogation from these rules is needed to avoid significant delay in developing life-saving vaccines and treatments.
He also said the discussion should start whether to launch emergency inoculation of experimental vaccines "right now".